Acquiring Company
Laprophan Group
Acquired Company
Corporate Investment Holding (CIH)
MoroccoCasablancaManufacturingBiotechnologyHealth CarePharmaceuticalManufacturingBiotechnologyPharmaceuticalDescription
Laprophan has acquired 100% of the shares in Corporate Investment Holding, enhancing its pharmaceutical portfolio. This acquisition aligns with Laprophan's expansion strategy following several earlier purchases in the sector.
Quick answer
Laprophan Group is acquiring Corporate Investment Holding (CIH), announced October 21, 2026. Laprophan Group is based in Morocco.
- How much did Laprophan Group pay for Corporate Investment Holding (CIH)?
- The deal value was not disclosed.
- What does Laprophan Group do?
- Laprophan Group is a leading pharmaceutical organization based in Morocco, specializing in the development and manufacturing of high-quality medicines.
- Where are Laprophan Group and Corporate Investment Holding (CIH) based?
- Laprophan Group is based in Morocco. Corporate Investment Holding (CIH) is based in Casablanca, Casablanca Settat, Morocco.
- Who are the decision-makers at Laprophan Group?
- Fundz holds 1 contact at Laprophan Group. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Pharmaceutical and Pharmaceutical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Zeria Pharmaceutical acquires Haupt Pharma Wulfling (October 25, 2026)
- PAI Pharma acquires Nexus Pharmaceuticals (November 12, 2026)
- Indivior Pharmaceuticals Completes Acquisition of Supernus Pharmaceuticals (November 2, 2026)
- Western Microsurgical acquires Q Surgical and Proficient Surgical (October 27, 2026)
- Merck KGaA to acquire Silence Therapeutics for $1.3B, $1.3B (October 19, 2026)
- Petauri acquires Franklin Pharmaceutical Consulting (October 8, 2026)
Who to call at Laprophan Group, and when
When Laprophan Group changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Laprophan Group raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Laprophan Group, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Laprophan Group. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Laprophan Group makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Corporate Investment Holding (CIH)?
Corporate Investment Holding (CIH) was acquired by Laprophan Group, based in Morocco. The deal was reported on October 21, 2026. Laprophan Group is a leading pharmaceutical organization based in Morocco, specializing in the development and manufacturing of high-quality medicines. Laprophan Group is privately held and operates in Manufacturing.
When did Laprophan Group acquire Corporate Investment Holding (CIH)?
Laprophan Group's acquisition of Corporate Investment Holding (CIH) was reported on October 21, 2026. Laprophan has acquired 100% of the shares in Corporate Investment Holding, enhancing its pharmaceutical portfolio. This acquisition aligns with Laprophan's expansion strategy following several earlier purchases in the sector. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Corporate Investment Holding (CIH) do?
Corporate Investment Holding (CIH) is the parent company of Polymedic, a well-established pharmaceutical laboratory in Morocco. CIH is involved in the development and distribution of various pharmaceutical products. It is privately held, operating in Manufacturing, and is based in Casablanca.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.